Use these statements to support your analysis Johnson Johnson As Reported Quarterly Balance Sheet Mergent Online Report Date 10 01 2023 07 02 2023 04 02 2023 10 02 2022 07 03 2022 04 03 2022 10 03 2021 07 04 2021 04 04 2021 3rd Quarter 2nd Quarter 1st Quarter 3rd Quarter 2nd Quarter 1st Quarter 3rd Quarter 2nd Quarter 1st Quarter Currency USD USD USD USD USD USD USD USD USD Audit Status Unaudited Unaudited Unaudited Unaudited Unaudited Unaudited Unaudited Unaudited Unaudited Consolidated Yes Yes Yes Yes Yes Yes Yes Yes Yes Scale Thousands Thousands Thousands Thousands Thousands Thousands Thousands Thousands Thousands Cash 3,214,000 Money market funds 3,503,000 Cash cash equivalents 19,728,000 21,183,000 19,170,000 11,355,000 10,983,000 10,463,000 17,604,000 14,332,000 12,671,000 Restricted cash 7,695,000 Marketable securities 3,783,000 7,322,000 5,443,000 22,724,000 21,585,000 19,925,000 13,397,000 10,974,000 11,948,000 Accounts receivable, trade, gross 14,958,000 16,982,000 16,557,000 16,091,000 16,362,000 15,828,000 15,134,000 15,105,000 15,208,000 Less allowances 160,000 205,000 207,000 201,000 223,000 234,000 223,000 234,000 270,000 Accounts receivable, trade 14,798,000 16,777,000 16,350,000 15,890,000 16,139,000 15,594,000 14,911,000 14,871,000 14,938,000 Raw materials supplies 2,233,000 2,419,000 2,267,000 1,730,000 1,696,000 1,679,000 1,587,000 1,576,000 1,557,000 Goods in process 1,961,000 1,944,000 1,866,000 2,106,000 2,324,000 2,629,000 2,164,000 2,307,000 2,034,000 Finished goods 7,004,000 8,525,000 8,676,000 7,839,000 7,417,000 6,682,000 6,636,000 6,217,000 6,361,000 Inventories 11,198,000 12,888,000 12,809,000 11,675,000 11,437,000 10,990,000 10,387,000 10,100,000 9,952,000 Prepaid expenses other receivables 4,196,000 Prepaid expenses other current assets 2,397,000 2,921,000 3,592,000 3,703,000 3,452,000 3,590,000 3,492,000 3,024,000 Government securities and obligations 4,728,000 Corporate debt securities 44,000 Reverse repurchase agreements 7,261,000 Time deposits 748,000 Other Sovereign Securities 2,000 Corporate debt securities 78,000 Non U S sovereign securities 150,000 Total current assets 53,703,000 60,567,000 64,388,000 65,236,000 63,847,000 60,424,000 59,889,000 53,769,000 52,533,000 Property, plant equipment at cost 45,626,000 51,218,000 50,367,000 46,681,000 47,144,000 47,702,000 47,347,000 47,201,000 46,430,000 Less accumulated depreciation 26,805,000 30,642,000 30,193,000 28,529,000 28,790,000 29,001,000 28,869,000 28,569,000 28,063,000 Property, plant equipment, net 18,821,000 20,576,000 20,174,000 18,152,000 18,354,000 18,701,000 18,478,000 18,632,000 18,367,000 Intangible assets, net 35,021,000 46,246,000 47,448,000 40,336,000 42,408,000 44,420,000 47,776,000 50,244,000 51,110,000 Goodwill 36,124,000 45,440,000 45,575,000 33,383,000 34,166,000 34,935,000 35,569,000 35,819,000 35,688,000 Deferred taxes on income 9,259,000 8,779,000 8,817,000 9,392,000 9,514,000 9,936,000 10,646,000 10,804,000 8,321,000 Other assets 13,133,000 10,078,000 9,567,000 8,625,000 9,435,000 9,939,000 6,870,000 7,172,000 6,538,000 Other Assets Balancing value 9,110,000 Equity investments 4,023,000 Total assets 166,061,000 191,686,000 195,969,000 175,124,000 177,724,000 178,355,000 179,228,000 176,440,000 172,557,000 Loans notes payable 2,000,000 11,701,000 17,979,000 4,424,000 4,305,000 4,297,000 3,798,000 3,173,000 3,350,000 Accounts payable 8,355,000 10,443,000 9,909,000 10,153,000 9,765,000 9,309,000 8,961,000 8,704,000 8,503,000 Accrued liabilities 10,101,000 10,605,000 11,204,000 11,953,000 12,607,000 13,006,000 13,812,000 10,485,000 13,223,000 Accrued rebates, returns promotions 15,808,000 15,672,000 14,784,000 14,021,000 13,447,000 12,972,000 12,683,000 12,450,000 11,919,000 Accrued compensation employee related obligations 3,337,000 3,062,000 2,231,000 3,006,000 2,717,000 2,098,000 3,146,000 2,709,000 2,060,000 Accrued taxes on income 2,687,000 4,266,000 1,986,000 1,980,000 1,708,000 2,161,000 1,200,000 1,877,000 Taxes on income 2,899,000 Loans and Notes Payable Current portion 1,870,000 Loans and Notes Payable 3,870,000 Total current liabilities 44,370,000 54,170,000 60,373,000 45,543,000 44,821,000 43,390,000 44,561,000 38,721,000 40,932,000 Notes 24,423,000 25,461,000 25,610,000 26,297,000 26,859,000 28,141,000 28,319,000 28,273,000 Debentures 9,412,000 9,410,000 1,985,000 1,985,000 1,985,000 1,984,000 1,984,000 1,983,000 Other long term debt 66,000 57,000 8,000 10,000 7,000 5,000 7,000 7,000 Long term debt 26,051,000 33,901,000 34,928,000 27,603,000 28,292,000 28,851,000 30,130,000 30,310,000 30,263,000 Deferred taxes on income 2,623,000 3,627,000 4,417,000 4,946,000 5,015,000 6,424,000 7,147,000 9,016,000 6,507,000 Employee related obligations 5,687,000 6,461,000 6,665,000 8,353,000 8,553,000 8,739,000 10,171,000 10,367,000 10,512,000 Long term taxes payable 2,540,000 2,536,000 4,296,000 4,162,000 4,162,000 5,745,000 5,770,000 5,722,000 6,568,000 Other liabilities 13,562,000 14,582,000 14,421,000 9,918,000 10,524,000 10,497,000 11,177,000 12,724,000 11,941,000 Total liabilities 94,833,000 115,277,000 125,100,000 100,525,000 101,367,000 103,646,000 108,956,000 106,860,000 106,723,000 Common stock 3,120,000 3,120,000 3,120,000 3,120,000 3,120,000 3,120,000 3,120,000 3,120,000 3,120,000 Foreign currency translation (7,376,000) (12,161,000) (11,994,000) (11,974,000) (10,722,000) (10,571,000) (9,179,000) (8,797,000) (8,662,000) Gain (loss) on securities (2,000) (6,000) (10,000) (38,000) (36,000) (16,000) 1,000 Employee benefit plans (1,035,000) (965,000) (2,358,000) (2,472,000) (2,538,000) (6,257,000) (6,490,000) (6,724,000) Gain (loss) on derivatives hedges (626,000) 67,000 343,000 (922,000) (613,000) (632,000) 21,000 187,000 57,000 Pension liability adjustment (776,000) Accumulated other comprehensive income (loss) (8,780,000) (13,135,000) (12,626,000) (15,292,000) (13,843,000) (13,757,000) (15,415,000) (15,100,000) (15,328,000) Retained earnings additional paid in capital 129,381,000 124,558,000 Retained earnings (accumulated deficit) 152,536,000 127,917,000 126,216,000 124,380,000 121,092,000 120,154,000 116,508,000 Less common stock held in treasury, at cost 75,648,000 44,217,000 44,183,000 41,146,000 39,136,000 39,034,000 38,525,000 38,594,000 38,466,000 Total Johnson Johnson shareholders equity 71,228,000 75,149,000 70,869,000 74,599,000 76,357,000 74,709,000 70,272,000 69,580,000 65,834,000 Total equity 71,228,000 76,409,000 Equity attributable to non controlling interest 1,260,000 As Reported Quarterly Income Statement Report Date 10 01 2023 07 02 2023 04 02 2023 10 02 2022 07 03 2022 04 03 2022 10 03 2021 07 04 2021 04 04 2021 3rd Quarter 2nd Quarter 1st Quarter 3rd Quarter 2nd Quarter 1st Quarter 3rd Quarter 2nd Quarter 1st Quarter Currency USD USD USD USD USD USD USD USD USD Audit Status Unaudited Unaudited Unaudited Unaudited Unaudited Unaudited Unaudited Unaudited Unaudited Consolidated Yes Yes Yes Yes Yes Yes Yes Yes Yes Scale Thousands Thousands Thousands Thousands Thousands Thousands Thousands Thousands Thousands Sales to customers 21,351,000 25,530,000 24,746,000 23,791,000 24,020,000 23,426,000 23,338,000 23,312,000 22,321,000 Cost of products sold 6,606,000 8,212,000 8,395,000 7,807,000 7,919,000 7,598,000 7,250,000 7,587,000 7,063,000 Gross profit (loss) 14,745,000 17,318,000 16,351,000 15,984,000 16,101,000 15,828,000 16,088,000 15,725,000 15,258,000 Selling, marketing administrative expenses 5,400,000 6,665,000 6,138,000 6,089,000 6,226,000 5,938,000 6,000,000 6,073,000 5,432,000 Research development expense 3,447,000 3,829,000 3,563,000 3,597,000 3,703,000 3,462,000 3,422,000 3,394,000 3,178,000 In process research development expenses 206,000 49,000 610,000 900,000 Interest income 369,000 235,000 150,000 64,000 22,000 13,000 12,000 15,000 Interest expense, net of portion capitalized 192,000 346,000 215,000 51,000 38,000 10,000 20,000 40,000 63,000 Other income (expense), net (499,000) 60,000 (7,228,000) (493,000) (273,000) 102,000 (1,850,000) 488,000 882,000 Restructuring expenses 158,000 145,000 130,000 82,000 85,000 70,000 60,000 56,000 53,000 Interest income 374,000 Earnings (loss) before provision for taxes on income 5,217,000 6,762,000 (737,000) 5,822,000 5,840,000 5,862,000 3,849,000 6,662,000 7,429,000 Provision for (benefit from) taxes on income 908,000 1,618,000 (669,000) 1,364,000 1,026,000 713,000 182,000 384,000 1,232,000 Net earnings (loss) 26,028,000 5,144,000 (68,000) 4,458,000 4,814,000 5,149,000 3,667,000 6,278,000 6,197,000 Weighted average shares outstanding basic 2,522,900 2,598,400 2,605,500 2,627,900 2,629,600 2,629,200 2,632,600 2,632,500 2,631,600 Weighted average shares outstanding diluted 2,549,700 2,625,700 2,605,500 2,661,300 2,667,900 2,666,500 2,674,900 2,671,600 2,672,700 Year end shares outstanding 2,407,178 2,598,143 2,598,324 2,616,882 2,629,032 2,629,384 2,632,485 2,631,989 2,632,702 Net earnings (loss) per share from continuing operations basic 1 71 Net earnings (loss) per share from discontinued operations basic 8 61 Net earnings (loss) per share basic 10 32 1 98 (0 03) 1 7 1 83 1 96 1 39 2 38 2 35 Net earnings (loss) per share from continuing operations diluted 1 69 Net earnings (loss) per share from discontinued operations diluted 8 52 Net earnings (loss) per share diluted 10 21 1 96 (0 03) 1 68 1 8 1 93 1 37 2 35 2 32 Cash dividends per share 1 19 1 19 1 13 1 13 1 13 1 06 1 06 1 06 1 01 Total revenues 21,351,000 Net earnings from Discontinued Operations, net of tax 21,719,000 Sale of Discontinued Operations before Tax Gain Loss 21,202,000 Discontinued Operations Tax Impacts Gain Loss on Sale 517,000 As Reported Quarterly Retained Earnings Report Date 07 02 2023 04 02 2023 10 02 2022 07 03 2022 04 03 2022 10 03 2021 07 04 2021 04 04 2021 2nd Quarter 1st Quarter 3rd Quarter 2nd Quarter 1st Quarter 3rd Quarter 2nd Quarter 1st Quarter Currency USD USD USD USD USD USD USD USD Audit Status Unaudited Unaudited Unaudited Unaudited Unaudited Unaudited Unaudited Unaudited Consolidated Yes Yes Yes Yes Yes Yes Yes Yes Scale Thousands Thousands Thousands Thousands Thousands Thousands Thousands Thousands Previous retained earnings (accumulated deficit) 124,558,000 128,345,000 126,216,000 124,380,000 123,060,000 120,154,000 116,508,000 113,890,000 Cash dividends paid 3,092,000 2,942,000 2,970,000 2,971,000 2,787,000 2,791,000 2,791,000 2,659,000 Employee compensation stock option plans (301,000) 777,000 (213,000) 7,000 1,042,000 (62,000) (159,000) 920,000 Kenvue IPO 2,470,000 Retained earnings (accumulated deficit) 129,381,000 124,558,000 127,917,000 126,216,000 124,380,000 121,092,000 120,154,000 116,508,000 As Reported Quarterly Cash Flow Report Date 10 01 2023 07 02 2023 04 02 2023 10 02 2022 07 03 2022 04 03 2022 10 03 2021 07 04 2021 04 04 2021 3rd Quarter 2nd Quarter 1st Quarter 3rd Quarter 2nd Quarter 1st Quarter 3rd Quarter 2nd Quarter 1st Quarter Currency USD USD USD USD USD USD USD USD USD Audit Status Unaudited Unaudited Unaudited Unaudited Unaudited Unaudited Unaudited Unaudited Unaudited Consolidated Yes Yes Yes Yes Yes Yes Yes Yes Yes Scale Thousands Thousands Thousands Thousands Thousands Thousands Thousands Thousands Thousands Net earnings (loss) 31,104,000 5,076,000 (68,000) 14,421,000 9,963,000 5,149,000 16,142,000 12,475,000 6,197,000 Depreciation amortization of property intangibles 5,643,000 3,814,000 1,880,000 5,198,000 3,513,000 1,769,000 5,547,000 3,733,000 1,894,000 Stock based compensation 984,000 688,000 306,000 925,000 644,000 278,000 920,000 661,000 307,000 Asset write downs 388,000 426,000 787,000 747,000 610,000 964,000 26,000 14,000 Net loss (gain) on sale of assets or businesses (117,000) (47,000) (8,000) (213,000) (213,000) (168,000) (601,000) (601,000) (580,000) Deferred tax provision (benefit) (1,782,000) (2,342,000) (1,543,000) (2,488,000) (2,349,000) (926,000) (2,564,000) (685,000) (730,000) Credit losses accounts receivable allowances 1,000 (14,000) (3,000) 6,000 (60,000) (52,000) (13,000) Accounts receivable (851,000) (599,000) (54,000) (1,591,000) (1,386,000) (427,000) (1,818,000) (1,566,000) (1,604,000) Inventories (1,447,000) (741,000) (524,000) (1,877,000) (1,257,000) (600,000) (1,178,000) (818,000) (695,000) Accounts payable accrued liabilities 664,000 (1,061,000) (2,572,000) 141,000 (1,170,000) (2,817,000) 182,000 (4,050,000) (2,336,000) Other current non current assets (1,366,000) (1,144,000) (915,000) 4,563,000 3,527,000 995,000 2,082,000 1,415,000 2,522,000 Other current non current liabilities 2,260,000 3,407,000 6,328,000 (4,008,000) (2,456,000) 110,000 (1,938,000) (1,150,000) (902,000) Asset write 820,000 Gain on Kenvue separation (20,984,000) Net cash flows from operating activities 14,928,000 7,439,000 3,257,000 15,844,000 9,560,000 3,979,000 17,678,000 9,388,000 4,074,000 Additions to property, plant equipment (2,954,000) (1,987,000) (863,000) (2,422,000) (1,470,000) (607,000) (2,237,000) (1,490,000) (677,000) Proceeds from the disposal of assets or businesses, net 237,000 116,000 40,000 322,000 314,000 248,000 666,000 654,000 603,000 Acquisitions, net of cash acquired (522,000) (523,000) (252,000) Purchases of investments (9,981,000) (9,688,000) (3,774,000) (31,163,000) (22,048,000) (9,018,000) (18,843,000) (12,264,000) (5,994,000) Sales of investments 15,787,000 11,877,000 7,766,000 26,324,000 17,634,000 6,303,000 16,809,000 12,453,000 5,233,000 Credit support agreements activity, net (798,000) 158,000 (305,000) (10,000) (249,000) 696,000 441,000 751,000 Other investing activities (92,000) Other investing activities (primarily licenses milestones) 19,000 (12,000) (208,000) (170,000) (59,000) (414,000) (398,000) (101,000) Proceeds from credit support agreements (917,000) Net cash flows from investing activites 2,080,000 (461,000) 3,315,000 (7,974,000) (6,273,000) (3,634,000) (3,323,000) (604,000) (185,000) Dividends to shareholders (8,905,000) (6,034,000) (2,942,000) (8,728,000) (5,758,000) (2,787,000) (8,241,000) (5,450,000) (2,659,000) Repurchase of common stock (4,838,000) (3,918,000) (3,537,000) (4,715,000) (2,550,000) (1,577,000) (2,460,000) (2,069,000) (1,438,000) Proceeds from short term debt 12,462,000 12,221,000 11,094,000 7,099,000 4,371,000 3,019,000 1,283,000 498,000 23,000 Repayment of short term debt (21,645,000) (13,611,000) (5,388,000) (4,808,000) (2,201,000) (856,000) (821,000) (689,000) (475,000) Proceeds from long term debt, net of issuance costs 8,047,000 7,674,000 7,674,000 1,000 2,000 3,000 1,000 1,000 Repayment of long term debt (502,000) (501,000) (500,000) (2,133,000) (2,132,000) (2,132,000) (1,452,000) (1,451,000) (1,001,000) Proceeds from the exercise of stock options 907,000 Proceeds from the exercise of stock options or employee withholding tax on stock awards, net 254,000 (11,000) 907,000 820,000 321,000 808,000 543,000 236,000 Credit support agreements activity, net 62,000 (126,000) (13,000) 1,678,000 813,000 (235,000) 168,000 130,000 212,000 Proceeds from Kenvue, Inc initial public offering 4,241,000 4,241,000 Other financing activities 115,000 (53,000) (239,000) 128,000 (11,000) (138,000) 101,000 83,000 (24,000) Cash transferred to Kenvue at separation (1,114,000) Net cash flows from financing activities (11,170,000) 147,000 6,138,000 (10,571,000) (6,646,000) (4,385,000) (10,611,000) (8,404,000) (5,125,000) Effect of exchange rate changes on cash cash equivalents (237,000) (69,000) 28,000 (431,000) (145,000) 16,000 (125,000) (33,000) (78,000) Increase (decrease) in cash cash equivalents 5,601,000 7,056,000 (3,132,000) (3,504,000) (4,024,000) 3,619,000 347,000 (1,314,000) Increase (decrease) in cash, cash equivalents restricted cash 12,738,000 Cash cash equivalents beginning of period 14,127,000 14,127,000 14,127,000 14,487,000 14,487,000 14,487,000 13,985,000 13,985,000 13,985,000 Cash cash equivalents, end of period 21,183,000 11,355,000 10,983,000 10,463,000 17,604,000 14,332,000 12,671,000 Cash, cash equivalents restricted cash, end of period 19,728,000 26,865,000 Part 1 Financial Analysis Johnson and Johnson Financial Calculations Accurately calculate financial formulas to figure out the business's current financial health You must calculate the following Working capital Current ratio Debt ratio Earnings per share Price earnings ratio Total asset turnover ratio Financial leverage Net profit margin Return on assets Return on equity Working Capital Management Explain the impact of working capital management on the business's operations Provide examples to support claims Financing Explain how a business finances its operations and expansion Short Term Financing Explain how potential short term financing sources could help the business raise funds for improving its financial health Base response on the business's current financial information Bond Investment Discuss the risks and benefits of the business investing in a corporate bond Include the necessary ethical factors, appropriate calculations, and examples to support your analysis Use the Project Two Financial Assumptions document and the Bonds section of the Net Present Value (NPV) worksheet in Financial Formulas workbook Capital Equipment Discuss the risks and benefits of the business investing in capital equipment Include the necessary ethical factors, appropriate calculations, and examples to support your analysis Use the Assumptions document and the Equipment section of the Net Present Value (NPV) worksheet in the Financial Formulas workbook Building Discuss the risks and benefits of the business investing in a building Include the necessary ethical factors, appropriate calculations, and examples to support your analysis Use the Assumptions document and the Building section of the NPV worksheet Ratios Most Recent Fiscal Qtr CURRENT RATIO (Current Assets Current Liabilities) Current Assets $ Current Liabilities $ $ WORKING CAPITAL (Current Assets Current Liabilities) Current Assets $ Current Liabilities $ $ DEBT RATIO (Total Liabilities Total Assets) Total Liabilities $ Total Assets $ $ EARNINGS PER SHARE (Net Income Weighted Average Common Shares Outstanding) Net Income $ Shares Outstanding $ $ PRICE EARNINGS RATIO (Share Price (end of quarter EPS) Stock Price $ EPS $ $ TOTAL ASSET TURNOVER RATIO (Total Revenue Total Assets) Total Revenue $ Total Assets $ $ FINANCIAL LEVERAGE (Total Assets Shareholder's Equity) Total Assets Shareholder's Equity DIV 0 NET PROFIT MARGIN (Net Income Total Revenue) Net Income $ Total Revenue $ $ RETURN ON ASSETS (Net Income Total Assets) Net Income $ Total Assets $ $ RETURN ON EQUITY (Net Income Preferred Dividends Shareholder's Equity) NI Pref Div $ Shareholder's Equity $ $ Ratios Same fiscal Qtr 1 Yr Ago CURRENT RATIO (Current Assets Current Liabilities) Current Assets $ Current Liabilities $ $ WORKING CAPITAL (Current Assets Current Liabilities) Current Assets $ Current Liabilities $ $ DEBT RATIO (Total Liabilities Total Assets) Total Liabilities $ Total Assets $ $ EARNINGS PER SHARE (Net Income Weighted Average Common Shares Outstanding) Net Income $ Shares Outstanding $ $ PRICE EARNINGS RATIO (Share Price (end of quarter EPS) Stock Price $ EPS $ $ TOTAL ASSET TURNOVER RATIO (Total Revenue Total Assets) Total Revenue $ Total Assets $ $ FINANCIAL LEVERAGE (Total Assets Shareholder's Equity) Total Assets $ Shareholder's Equity $ $ NET PROFIT MARGIN (Net Income Total Revenue) Net Income $ Total Revenue $ $ RETURN ON ASSETS (Net Income Total Assets) Net Income $ Total Assets $ $ RETURN ON EQUITY (Net Income Preferred Dividends Shareholder's Equity) NI Pref Div $ Shareholder's Equity $ $ Net Present Value (NPV) Calculator Building Initial Investment Year 1 2 3 4 5 6 7 8 9 10 Annual Cash Inflows Cash Flows $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 Discount Rate NPV $0 Year 11 12 13 14 15 16 17 18 19 20 Number of Years Cash Flows $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 Salvage Value Equipment Initial Investment Year 1 2 3 4 5 6 7 8 9 10 Annual Cash Inflows Cash Flows $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 Discount Rate NPV $0 Year 11 12 13 14 15 16 17 18 19 20 Number of Years Cash Flows $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 Salvage Value Bonds Initial Investment Annual Cash Inflows Discount Rate NPV $0 Year 1 2 3 4 5 6 7 8 9 10 Number of Years Cash Flows $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 Principal Returned Part 2 Financial Evaluation In this section of the report, you will determine which of the three available investments are good financing options and describe the business's likely future financial performance Bond Investment Determine if the bond investment is a good financing option for the business's financial health Use your financial analy

The Answer is in the image, click to view ...

Question: Use these statements to support your analysis Johnson & Johnson As Reported Quarterly Balance Sheet Mergent Online Report Date 10/01/2023 07/02/2023 04/02/2023 10/02/2022 07/03/2022 04/03/2022

Use these statements to support your analysis

Johnson & Johnson As Reported Quarterly Balance Sheet Mergent Online

Report Date	10/01/2023	07/02/2023	04/02/2023	10/02/2022	07/03/2022	04/03/2022	10/03/2021	07/04/2021	04/04/2021
	3rd Quarter	2nd Quarter	1st Quarter	3rd Quarter	2nd Quarter	1st Quarter	3rd Quarter	2nd Quarter	1st Quarter
Currency	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Status	Unaudited	Unaudited	Unaudited	Unaudited	Unaudited	Unaudited	Unaudited	Unaudited	Unaudited
Consolidated	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes
Scale	Thousands	Thousands	Thousands	Thousands	Thousands	Thousands	Thousands	Thousands	Thousands
Cash	3,214,000	-	-	-	-	-	-	-	-
Money market funds	3,503,000	-	-	-	-	-	-	-	-
Cash & cash equivalents	19,728,000	21,183,000	19,170,000	11,355,000	10,983,000	10,463,000	17,604,000	14,332,000	12,671,000
Restricted cash	-	-	7,695,000	-	-	-	-	-	-
Marketable securities	3,783,000	7,322,000	5,443,000	22,724,000	21,585,000	19,925,000	13,397,000	10,974,000	11,948,000
Accounts receivable, trade, gross	14,958,000	16,982,000	16,557,000	16,091,000	16,362,000	15,828,000	15,134,000	15,105,000	15,208,000
Less: allowances	160,000	205,000	207,000	201,000	223,000	234,000	223,000	234,000	270,000
Accounts receivable, trade	14,798,000	16,777,000	16,350,000	15,890,000	16,139,000	15,594,000	14,911,000	14,871,000	14,938,000
Raw materials & supplies	2,233,000	2,419,000	2,267,000	1,730,000	1,696,000	1,679,000	1,587,000	1,576,000	1,557,000
Goods in process	1,961,000	1,944,000	1,866,000	2,106,000	2,324,000	2,629,000	2,164,000	2,307,000	2,034,000
Finished goods	7,004,000	8,525,000	8,676,000	7,839,000	7,417,000	6,682,000	6,636,000	6,217,000	6,361,000
Inventories	11,198,000	12,888,000	12,809,000	11,675,000	11,437,000	10,990,000	10,387,000	10,100,000	9,952,000
Prepaid expenses & other receivables	4,196,000	-	-	-	-	-	-	-	-
Prepaid expenses & other current assets	-	2,397,000	2,921,000	3,592,000	3,703,000	3,452,000	3,590,000	3,492,000	3,024,000
Government securities and obligations	4,728,000	-	-	-	-	-	-	-	-
Corporate debt securities	44,000	-	-	-	-	-	-	-	-
Reverse repurchase agreements	7,261,000	-	-	-	-	-	-	-	-
Time deposits	748,000	-	-	-	-	-	-	-	-
Other Sovereign Securities	2,000	-	-	-	-	-	-	-	-
Corporate debt securities	78,000	-	-	-	-	-	-	-	-
Non-U.S. sovereign securities	150,000	-	-	-	-	-	-	-	-
Total current assets	53,703,000	60,567,000	64,388,000	65,236,000	63,847,000	60,424,000	59,889,000	53,769,000	52,533,000
Property, plant & equipment at cost	45,626,000	51,218,000	50,367,000	46,681,000	47,144,000	47,702,000	47,347,000	47,201,000	46,430,000
Less: accumulated depreciation	26,805,000	30,642,000	30,193,000	28,529,000	28,790,000	29,001,000	28,869,000	28,569,000	28,063,000
Property, plant & equipment, net	18,821,000	20,576,000	20,174,000	18,152,000	18,354,000	18,701,000	18,478,000	18,632,000	18,367,000
Intangible assets, net	35,021,000	46,246,000	47,448,000	40,336,000	42,408,000	44,420,000	47,776,000	50,244,000	51,110,000
Goodwill	36,124,000	45,440,000	45,575,000	33,383,000	34,166,000	34,935,000	35,569,000	35,819,000	35,688,000
Deferred taxes on income	9,259,000	8,779,000	8,817,000	9,392,000	9,514,000	9,936,000	10,646,000	10,804,000	8,321,000
Other assets	13,133,000	10,078,000	9,567,000	8,625,000	9,435,000	9,939,000	6,870,000	7,172,000	6,538,000
Other Assets - Balancing value	9,110,000	-	-	-	-	-	-	-	-
Equity investments	4,023,000	-	-	-	-	-	-	-	-
Total assets	166,061,000	191,686,000	195,969,000	175,124,000	177,724,000	178,355,000	179,228,000	176,440,000	172,557,000
Loans & notes payable	2,000,000	11,701,000	17,979,000	4,424,000	4,305,000	4,297,000	3,798,000	3,173,000	3,350,000
Accounts payable	8,355,000	10,443,000	9,909,000	10,153,000	9,765,000	9,309,000	8,961,000	8,704,000	8,503,000
Accrued liabilities	10,101,000	10,605,000	11,204,000	11,953,000	12,607,000	13,006,000	13,812,000	10,485,000	13,223,000
Accrued rebates, returns & promotions	15,808,000	15,672,000	14,784,000	14,021,000	13,447,000	12,972,000	12,683,000	12,450,000	11,919,000
Accrued compensation & employee related obligations	3,337,000	3,062,000	2,231,000	3,006,000	2,717,000	2,098,000	3,146,000	2,709,000	2,060,000
Accrued taxes on income	-	2,687,000	4,266,000	1,986,000	1,980,000	1,708,000	2,161,000	1,200,000	1,877,000
Taxes on income	2,899,000	-	-	-	-	-	-	-	-
Loans and Notes Payable Current portion	1,870,000	-	-	-	-	-	-	-	-
Loans and Notes Payable	3,870,000	-	-	-	-	-	-	-	-
Total current liabilities	44,370,000	54,170,000	60,373,000	45,543,000	44,821,000	43,390,000	44,561,000	38,721,000	40,932,000
Notes	-	24,423,000	25,461,000	25,610,000	26,297,000	26,859,000	28,141,000	28,319,000	28,273,000
Debentures	-	9,412,000	9,410,000	1,985,000	1,985,000	1,985,000	1,984,000	1,984,000	1,983,000
Other long-term debt	-	66,000	57,000	8,000	10,000	7,000	5,000	7,000	7,000
Long-term debt	26,051,000	33,901,000	34,928,000	27,603,000	28,292,000	28,851,000	30,130,000	30,310,000	30,263,000
Deferred taxes on income	2,623,000	3,627,000	4,417,000	4,946,000	5,015,000	6,424,000	7,147,000	9,016,000	6,507,000
Employee related obligations	5,687,000	6,461,000	6,665,000	8,353,000	8,553,000	8,739,000	10,171,000	10,367,000	10,512,000
Long-term taxes payable	2,540,000	2,536,000	4,296,000	4,162,000	4,162,000	5,745,000	5,770,000	5,722,000	6,568,000
Other liabilities	13,562,000	14,582,000	14,421,000	9,918,000	10,524,000	10,497,000	11,177,000	12,724,000	11,941,000
Total liabilities	94,833,000	115,277,000	125,100,000	100,525,000	101,367,000	103,646,000	108,956,000	106,860,000	106,723,000
Common stock	3,120,000	3,120,000	3,120,000	3,120,000	3,120,000	3,120,000	3,120,000	3,120,000	3,120,000
Foreign currency translation	(7,376,000)	(12,161,000)	(11,994,000)	(11,974,000)	(10,722,000)	(10,571,000)	(9,179,000)	(8,797,000)	(8,662,000)
Gain (loss) on securities	(2,000)	(6,000)	(10,000)	(38,000)	(36,000)	(16,000)	-	-	1,000
Employee benefit plans	-	(1,035,000)	(965,000)	(2,358,000)	(2,472,000)	(2,538,000)	(6,257,000)	(6,490,000)	(6,724,000)
Gain (loss) on derivatives & hedges	(626,000)	67,000	343,000	(922,000)	(613,000)	(632,000)	21,000	187,000	57,000
Pension liability adjustment	(776,000)	-	-	-	-	-	-	-	-
Accumulated other comprehensive income (loss)	(8,780,000)	(13,135,000)	(12,626,000)	(15,292,000)	(13,843,000)	(13,757,000)	(15,415,000)	(15,100,000)	(15,328,000)
Retained earnings & additional paid-in capital	-	129,381,000	124,558,000	-	-	-	-	-	-
Retained earnings (accumulated deficit)	152,536,000	-	-	127,917,000	126,216,000	124,380,000	121,092,000	120,154,000	116,508,000
Less: common stock held in treasury, at cost	75,648,000	44,217,000	44,183,000	41,146,000	39,136,000	39,034,000	38,525,000	38,594,000	38,466,000
Total Johnson & Johnson shareholders? equity	71,228,000	75,149,000	70,869,000	74,599,000	76,357,000	74,709,000	70,272,000	69,580,000	65,834,000
Total equity	71,228,000	76,409,000	-	-	-	-	-	-	-
Equity attributable to non-controlling interest	-	1,260,000	-	-	-	-	-	-	-

As Reported Quarterly Income Statement

Report Date	10/01/2023	07/02/2023	04/02/2023	10/02/2022	07/03/2022	04/03/2022	10/03/2021	07/04/2021	04/04/2021
	3rd Quarter	2nd Quarter	1st Quarter	3rd Quarter	2nd Quarter	1st Quarter	3rd Quarter	2nd Quarter	1st Quarter
Currency	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Status	Unaudited	Unaudited	Unaudited	Unaudited	Unaudited	Unaudited	Unaudited	Unaudited	Unaudited
Consolidated	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes
Scale	Thousands	Thousands	Thousands	Thousands	Thousands	Thousands	Thousands	Thousands	Thousands
Sales to customers	21,351,000	25,530,000	24,746,000	23,791,000	24,020,000	23,426,000	23,338,000	23,312,000	22,321,000
Cost of products sold	6,606,000	8,212,000	8,395,000	7,807,000	7,919,000	7,598,000	7,250,000	7,587,000	7,063,000
Gross profit (loss)	14,745,000	17,318,000	16,351,000	15,984,000	16,101,000	15,828,000	16,088,000	15,725,000	15,258,000
Selling, marketing & administrative expenses	5,400,000	6,665,000	6,138,000	6,089,000	6,226,000	5,938,000	6,000,000	6,073,000	5,432,000
Research & development expense	3,447,000	3,829,000	3,563,000	3,597,000	3,703,000	3,462,000	3,422,000	3,394,000	3,178,000
In-process research & development expenses	206,000	-	49,000	-	-	610,000	900,000	-	-
Interest income	-	369,000	235,000	150,000	64,000	22,000	13,000	12,000	15,000
Interest expense, net of portion capitalized	192,000	346,000	215,000	51,000	38,000	10,000	20,000	40,000	63,000
Other income (expense), net	(499,000)	60,000	(7,228,000)	(493,000)	(273,000)	102,000	(1,850,000)	488,000	882,000
Restructuring expenses	158,000	145,000	130,000	82,000	85,000	70,000	60,000	56,000	53,000
Interest income	374,000	-	-	-	-	-	-	-	-
Earnings (loss) before provision for taxes on income	5,217,000	6,762,000	(737,000)	5,822,000	5,840,000	5,862,000	3,849,000	6,662,000	7,429,000
Provision for (benefit from) taxes on income	908,000	1,618,000	(669,000)	1,364,000	1,026,000	713,000	182,000	384,000	1,232,000
Net earnings (loss)	26,028,000	5,144,000	(68,000)	4,458,000	4,814,000	5,149,000	3,667,000	6,278,000	6,197,000
Weighted average shares outstanding - basic	2,522,900	2,598,400	2,605,500	2,627,900	2,629,600	2,629,200	2,632,600	2,632,500	2,631,600
Weighted average shares outstanding - diluted	2,549,700	2,625,700	2,605,500	2,661,300	2,667,900	2,666,500	2,674,900	2,671,600	2,672,700
Year end shares outstanding	2,407,178	2,598,143	2,598,324	2,616,882	2,629,032	2,629,384	2,632,485	2,631,989	2,632,702
Net earnings (loss) per share from continuing operations - basic	1.71	-	-	-	-	-	-	-	-
Net earnings (loss) per share from discontinued operations - basic	8.61	-	-	-	-	-	-	-	-
Net earnings (loss) per share - basic	10.32	1.98	(0.03)	1.7	1.83	1.96	1.39	2.38	2.35
Net earnings (loss) per share from continuing operations - diluted	1.69	-	-	-	-	-	-	-	-
Net earnings (loss) per share from discontinued operations - diluted	8.52	-	-	-	-	-	-	-	-
Net earnings (loss) per share - diluted	10.21	1.96	(0.03)	1.68	1.8	1.93	1.37	2.35	2.32
Cash dividends per share	1.19	1.19	1.13	1.13	1.13	1.06	1.06	1.06	1.01
Total revenues	21,351,000	-	-	-	-	-	-	-	-
Net earnings from Discontinued Operations, net of tax	21,719,000	-	-	-	-	-	-	-	-
Sale of Discontinued Operations before Tax - Gain/Loss	21,202,000	-	-	-	-	-	-	-	-
Discontinued Operations - Tax Impacts - Gain/Loss on Sale	517,000	-	-	-	-	-	-	-	-

As Reported Quarterly Retained Earnings

Report Date	07/02/2023	04/02/2023	10/02/2022	07/03/2022	04/03/2022	10/03/2021	07/04/2021	04/04/2021
	2nd Quarter	1st Quarter	3rd Quarter	2nd Quarter	1st Quarter	3rd Quarter	2nd Quarter	1st Quarter
Currency	USD	USD	USD	USD	USD	USD	USD	USD
Audit Status	Unaudited	Unaudited	Unaudited	Unaudited	Unaudited	Unaudited	Unaudited	Unaudited
Consolidated	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes
Scale	Thousands	Thousands	Thousands	Thousands	Thousands	Thousands	Thousands	Thousands
Previous retained earnings (accumulated deficit)	124,558,000	128,345,000	126,216,000	124,380,000	123,060,000	120,154,000	116,508,000	113,890,000
Cash dividends paid	3,092,000	2,942,000	2,970,000	2,971,000	2,787,000	2,791,000	2,791,000	2,659,000
Employee compensation & stock option plans	(301,000)	777,000	(213,000)	7,000	1,042,000	(62,000)	(159,000)	920,000
Kenvue IPO	2,470,000	-	-	-	-	-	-	-
Retained earnings (accumulated deficit)	129,381,000	124,558,000	127,917,000	126,216,000	124,380,000	121,092,000	120,154,000	116,508,000

As Reported Quarterly Cash Flow

Report Date	10/01/2023	07/02/2023	04/02/2023	10/02/2022	07/03/2022	04/03/2022	10/03/2021	07/04/2021	04/04/2021
	3rd Quarter	2nd Quarter	1st Quarter	3rd Quarter	2nd Quarter	1st Quarter	3rd Quarter	2nd Quarter	1st Quarter
Currency	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Status	Unaudited	Unaudited	Unaudited	Unaudited	Unaudited	Unaudited	Unaudited	Unaudited	Unaudited
Consolidated	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes
Scale	Thousands	Thousands	Thousands	Thousands	Thousands	Thousands	Thousands	Thousands	Thousands
Net earnings (loss)	31,104,000	5,076,000	(68,000)	14,421,000	9,963,000	5,149,000	16,142,000	12,475,000	6,197,000
Depreciation & amortization of property & intangibles	5,643,000	3,814,000	1,880,000	5,198,000	3,513,000	1,769,000	5,547,000	3,733,000	1,894,000
Stock based compensation	984,000	688,000	306,000	925,000	644,000	278,000	920,000	661,000	307,000
Asset write-downs	-	388,000	426,000	787,000	747,000	610,000	964,000	26,000	14,000
Net loss (gain) on sale of assets or businesses	(117,000)	(47,000)	(8,000)	(213,000)	(213,000)	(168,000)	(601,000)	(601,000)	(580,000)
Deferred tax provision (benefit)	(1,782,000)	(2,342,000)	(1,543,000)	(2,488,000)	(2,349,000)	(926,000)	(2,564,000)	(685,000)	(730,000)
Credit losses & accounts receivable allowances	-	-	1,000	(14,000)	(3,000)	6,000	(60,000)	(52,000)	(13,000)
Accounts receivable	(851,000)	(599,000)	(54,000)	(1,591,000)	(1,386,000)	(427,000)	(1,818,000)	(1,566,000)	(1,604,000)
Inventories	(1,447,000)	(741,000)	(524,000)	(1,877,000)	(1,257,000)	(600,000)	(1,178,000)	(818,000)	(695,000)
Accounts payable & accrued liabilities	664,000	(1,061,000)	(2,572,000)	141,000	(1,170,000)	(2,817,000)	182,000	(4,050,000)	(2,336,000)
Other current & non-current assets	(1,366,000)	(1,144,000)	(915,000)	4,563,000	3,527,000	995,000	2,082,000	1,415,000	2,522,000
Other current & non-current liabilities	2,260,000	3,407,000	6,328,000	(4,008,000)	(2,456,000)	110,000	(1,938,000)	(1,150,000)	(902,000)
Asset write	820,000	-	-	-	-	-	-	-	-
Gain on Kenvue separation	(20,984,000)	-	-	-	-	-	-	-	-
Net cash flows from operating activities	14,928,000	7,439,000	3,257,000	15,844,000	9,560,000	3,979,000	17,678,000	9,388,000	4,074,000
Additions to property, plant & equipment	(2,954,000)	(1,987,000)	(863,000)	(2,422,000)	(1,470,000)	(607,000)	(2,237,000)	(1,490,000)	(677,000)
Proceeds from the disposal of assets or businesses, net	237,000	116,000	40,000	322,000	314,000	248,000	666,000	654,000	603,000
Acquisitions, net of cash acquired	-	-	-	(522,000)	(523,000)	(252,000)	-	-	-
Purchases of investments	(9,981,000)	(9,688,000)	(3,774,000)	(31,163,000)	(22,048,000)	(9,018,000)	(18,843,000)	(12,264,000)	(5,994,000)
Sales of investments	15,787,000	11,877,000	7,766,000	26,324,000	17,634,000	6,303,000	16,809,000	12,453,000	5,233,000
Credit support agreements activity, net	-	(798,000)	158,000	(305,000)	(10,000)	(249,000)	696,000	441,000	751,000
Other investing activities	(92,000)	-	-	-	-	-	-	-	-
Other investing activities (primarily licenses & milestones)	-	19,000	(12,000)	(208,000)	(170,000)	(59,000)	(414,000)	(398,000)	(101,000)
Proceeds from credit support agreements	(917,000)	-	-	-	-	-	-	-	-
Net cash flows from investing activites	2,080,000	(461,000)	3,315,000	(7,974,000)	(6,273,000)	(3,634,000)	(3,323,000)	(604,000)	(185,000)
Dividends to shareholders	(8,905,000)	(6,034,000)	(2,942,000)	(8,728,000)	(5,758,000)	(2,787,000)	(8,241,000)	(5,450,000)	(2,659,000)
Repurchase of common stock	(4,838,000)	(3,918,000)	(3,537,000)	(4,715,000)	(2,550,000)	(1,577,000)	(2,460,000)	(2,069,000)	(1,438,000)
Proceeds from short-term debt	12,462,000	12,221,000	11,094,000	7,099,000	4,371,000	3,019,000	1,283,000	498,000	23,000
Repayment of short-term debt	(21,645,000)	(13,611,000)	(5,388,000)	(4,808,000)	(2,201,000)	(856,000)	(821,000)	(689,000)	(475,000)
Proceeds from long-term debt, net of issuance costs	8,047,000	7,674,000	7,674,000	1,000	2,000	-	3,000	1,000	1,000
Repayment of long-term debt	(502,000)	(501,000)	(500,000)	(2,133,000)	(2,132,000)	(2,132,000)	(1,452,000)	(1,451,000)	(1,001,000)
Proceeds from the exercise of stock options	907,000	-	-	-	-	-	-	-	-
Proceeds from the exercise of stock options or employee withholding tax on stock awards, net	-	254,000	(11,000)	907,000	820,000	321,000	808,000	543,000	236,000
Credit support agreements activity, net	62,000	(126,000)	(13,000)	1,678,000	813,000	(235,000)	168,000	130,000	212,000
Proceeds from Kenvue, Inc. initial public offering	4,241,000	4,241,000	-	-	-	-	-	-	-
Other financing activities	115,000	(53,000)	(239,000)	128,000	(11,000)	(138,000)	101,000	83,000	(24,000)
Cash transferred to Kenvue at separation	(1,114,000)	-	-	-	-	-	-	-	-
Net cash flows from financing activities	(11,170,000)	147,000	6,138,000	(10,571,000)	(6,646,000)	(4,385,000)	(10,611,000)	(8,404,000)	(5,125,000)
Effect of exchange rate changes on cash & cash equivalents	(237,000)	(69,000)	28,000	(431,000)	(145,000)	16,000	(125,000)	(33,000)	(78,000)
Increase (decrease) in cash & cash equivalents	5,601,000	7,056,000	-	(3,132,000)	(3,504,000)	(4,024,000)	3,619,000	347,000	(1,314,000)
Increase (decrease) in cash, cash equivalents & restricted cash	-	-	12,738,000	-	-	-	-	-	-
Cash & cash equivalents beginning of period	14,127,000	14,127,000	14,127,000	14,487,000	14,487,000	14,487,000	13,985,000	13,985,000	13,985,000
Cash & cash equivalents, end of period	-	21,183,000	-	11,355,000	10,983,000	10,463,000	17,604,000	14,332,000	12,671,000
Cash, cash equivalents & restricted cash, end of period	19,728,000	-	26,865,000	-	-	-	-	-	-

Part 1. Financial Analysis: Johnson and Johnson

Financial Calculations: Accurately calculate financial formulas to figure out the business's current financial health. You must calculate the following:
1. Working capital
2. Current ratio
3. Debt ratio
4. Earnings per share
5. Price/earnings ratio
6. Total asset turnover ratio
7. Financial leverage
8. Net profit margin
9. Return on assets.
10. Return on equity.
Working Capital Management: Explain the impact of working capital management on the business's operations. Provide examples to support claims.
Financing: Explain how a business finances its operations and expansion.
Short-Term Financing: Explain how potential short-term financing sources could help the business raise funds for improving its financial health. Base response on the business's current financial information.
Bond Investment: Discuss the risks and benefits of the business investing in a corporate bond. Include the necessary ethical factors, appropriate calculations, and examples to support your analysis. Use the Project Two Financial Assumptions document and the Bonds section of the Net Present Value (NPV) worksheet in Financial Formulas workbook.
Capital Equipment: Discuss the risks and benefits of the business investing in capital equipment. Include the necessary ethical factors, appropriate calculations, and examples to support your analysis. Use the Assumptions document and the Equipment section of the Net Present Value (NPV) worksheet in the Financial Formulas workbook.
Building: Discuss the risks and benefits of the business investing in a building. Include the necessary ethical factors, appropriate calculations, and examples to support your analysis. Use the Assumptions document and the Building section of the NPV worksheet

Ratios Most Recent Fiscal Qtr.

CURRENT RATIO (Current Assets / Current Liabilities)

Current Assets	$
Current Liabilities	$
			$

WORKING CAPITAL (Current Assets - Current Liabilities)

Current Assets	$
Current Liabilities	$
			$

DEBT RATIO (Total Liabilities / Total Assets)

Total Liabilities	$
Total Assets	$
		$

EARNINGS PER SHARE (Net Income / Weighted Average Common Shares Outstanding)

Net Income	$
Shares Outstanding	$
			$

PRICE EARNINGS RATIO (Share Price (end of quarter / EPS)

Stock Price	$
EPS	$
			$


TOTAL ASSET TURNOVER RATIO (Total Revenue / Total Assets)

Total Revenue	$
Total Assets	$
			$

FINANCIAL LEVERAGE (Total Assets / Shareholder's Equity)

Total Assets
Shareholder's Equity		#DIV/0!


NET PROFIT MARGIN (Net Income / Total Revenue)

Net Income	$
Total Revenue	$
			$

RETURN ON ASSETS (Net Income / Total Assets)

Net Income	$
Total Assets	$
			$

RETURN ON EQUITY (Net Income - Preferred Dividends / Shareholder's Equity)

NI - Pref. Div.	$
Shareholder's Equity	$
			$

Ratios Same fiscal Qtr 1 Yr Ago

CURRENT RATIO (Current Assets / Current Liabilities)

Current Assets	$
Current Liabilities	$		$


WORKING CAPITAL (Current Assets - Current Liabilities)

Current Assets	$
Current Liabilities	$		$


DEBT RATIO (Total Liabilities / Total Assets)

Total Liabilities	$
Total Assets	$		$


EARNINGS PER SHARE (Net Income / Weighted Average Common Shares Outstanding)

Net Income	$
Shares Outstanding	$		$


PRICE EARNINGS RATIO (Share Price (end of quarter / EPS)

Stock Price		$
EPS		$		$


TOTAL ASSET TURNOVER RATIO (Total Revenue / Total Assets)

Total Revenue	$
Total Assets	$	$


FINANCIAL LEVERAGE (Total Assets / Shareholder's Equity)

Total Assets	$
Shareholder's Equity	$	$


NET PROFIT MARGIN (Net Income / Total Revenue)

Net Income	$
Total Revenue	$	$


RETURN ON ASSETS (Net Income / Total Assets)

Net Income	$
Total Assets	$	$


RETURN ON EQUITY (Net Income - Preferred Dividends / Shareholder's Equity)

NI - Pref. Div.	$
Shareholder's Equity	$	$

Net Present Value (NPV) Calculator
Building

Initial Investment			Year	1	2	3	4	5	6	7	8	9	10
Annual Cash Inflows			Cash Flows	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Discount Rate	NPV =	$0	Year	11	12	13	14	15	16	17	18	19	20
Number of Years			Cash Flows	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Salvage Value



Equipment

Initial Investment			Year	1	2	3	4	5	6	7	8	9	10
Annual Cash Inflows			Cash Flows	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Discount Rate	NPV =	$0	Year	11	12	13	14	15	16	17	18	19	20
Number of Years			Cash Flows	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Salvage Value



Bonds

Initial Investment
Annual Cash Inflows
Discount Rate	NPV =	$0	Year	1	2	3	4	5	6	7	8	9	10
Number of Years			Cash Flows	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Principal Returned

Part 2. Financial Evaluation: In this section of the report, you will determine which of the three available investments are good financing options and describe the business's likely future financial performance.

Bond Investment: Determine if the bond investment is a good financing option for the business's financial health. Use your financial analy

Step by Step Solution

There are 3 Steps involved in it

1 Expert Approved Answer

Step: 1 Unlock blur-text-image

Question Has Been Solved by an Expert!

Get step-by-step solutions from verified subject matter experts

Step: 2 Unlock

Step: 3 Unlock

Students Have Also Explored These Related Accounting Questions!

Using Mergent Online, summarize the differences between the results from your financial calculations of the most recent fiscal quarter and the results of the same financial calculations of the same...

1. Financial Analysis: For this section, you will start with calculating the financial formulas listed in Part A. Use the most recent quarterly financial statements from your chosen business and the...

Show transcribed image text Scenario You are a financial analyst for the chosen business that you selected during your Module Two Journal assignment. Your supervisor has discovered last minute that...

Scenario You are a financial analyst for the chosen business that you selected during your Module Two Journal assignment. Your supervisor has discovered last minute that your business's board of...

FIN 320 Project Two Guidelines and Rubric Competencies In this project, you will demonstrate your mastery of the following competencies: Analyze financial and investment decisions that add value to...

Imagine you are an analyst for Kellogg's. The Kellogg's' board of directors wants updates on the business's financial health. Your supervisor has asked you to write a report that includes the...

The company is microsoft. Analyze financial and investment decisions that add value to the organization Analyze financing options to maximize investor value Scenario You chose a business for your...

You chose a business for your Module Two Journal ( Disney ) . Imagine you are an analyst for that business. The business s board of directors wants updates on the business s financial health. Your...

A job order cost accounting system is fully integrated into the general ledger of a company. Identify the major general ledger accounts used in a job order cost system. Explain how manufacturing...

Which of the following is a sign of effective CPR?

uestion 5 5 of 7 5 . ow does a taxpayer elect out of the special depreciation allowance? Attach a statement to the timely filed return ( including extensions ) identifying the classes of property for...

Dylan was receiving rental payments of $3,000 at the beginning of every month from the tenants of her commercial property. What would be the value of her property in the market if she wants to sell...